MOTS-c: What It Is and What It Does

What MOTS-c is

MOTS-c is unusual: it's a peptide encoded inside your mitochondria — the tiny 'power plants' within every cell. It is supplied as an analytical-grade reference material for laboratory research.

Where it comes from

MOTS-c stands for 'Mitochondrial ORF of the Twelve-S rRNA type-c.' It was identified in 2015 by researchers computationally scanning the small mitochondrial genome for hidden short reading frames -- stretches of code that could encode tiny peptides. They found MOTS-c tucked inside the 12S ribosomal RNA gene, making it one of a small group of 'mitochondrial-derived peptides.' What made it striking is its address: almost every peptide is written in the cell's nuclear DNA, but MOTS-c is encoded by the mitochondria themselves, hinting that these organelles send out their own molecular messages.

What it does — in plain terms

Almost all peptides come from instructions in the cell's main nucleus; MOTS-c comes from the mitochondria instead, and it seems to act like a status report on the cell's energy and stress levels. In animal and cell studies researchers look at how it affects metabolism — how cells burn fuel — and how they cope with physical stress. It's a favorite in aging and exercise research, because energy handling is central to both.

How it works

The simplest way to think about MOTS-c is as a metabolic status message from the mitochondria. Rather than acting on a single classic receptor, it appears to report on the cell's energy and stress state and help tune the response. In the foundational cell and animal work, one of its clearest actions is switching on AMPK -- a master 'low-fuel' sensor that shifts cells toward burning fuel more efficiently.

A second, more unusual theme is that MOTS-c can travel. Under metabolic stress, studies describe it moving from the mitochondria into the nucleus, where it helps regulate stress-adaptive genes -- a form of 'retrograde' signaling in which the power plant talks back to the cell's control center. Through this route it has been linked to antioxidant and metabolic gene programs.

Because energy handling sits underneath so much of physiology, researchers have followed these two threads -- AMPK-driven metabolism and stress-adaptive gene regulation -- into models of insulin resistance, muscle biology, and aging. It is worth stressing that this picture comes almost entirely from cell and animal experiments.

What the research shows

MOTS-c is one of the more intriguing molecules in metabolic and aging research precisely because of where it comes from -- but it is important to stay grounded. Almost all of the evidence below is preclinical, from cell cultures and animal models or from mechanistic and review articles; rigorous human trials are still lacking. With that caveat, here is what some of the key published work actually reports.

• Metabolites, 2023 — reviewed MOTS-c's links to metabolic disorders, outlining how the peptide affects glucose and lipid handling in preclinical models.
• American Journal of Physiology-Endocrinology and Metabolism, 2021 — examined how MOTS-c modulates signaling associated with skeletal-muscle atrophy in laboratory models.
• Frontiers in Endocrinology, 2023 — gave a broad overview of MOTS-c as a mitochondrial-derived peptide, summarizing its metabolic and stress-adaptive roles and its research potential.
• BioEssays, 2019 — described MOTS-c as a mitochondrial peptide that can move to the nucleus and regulate stress-adaptive gene expression, a form of retrograde signaling.
• Cell Metabolism, 2015 — identified MOTS-c as a mitochondrial-derived peptide that activates AMPK and reported that it reduced diet-induced obesity and insulin resistance in mice.
• Advanced Science, 2024 — investigated MOTS-c's mechanisms in ovarian-cancer cell models.
• Mitochondrion, 2023 — studied MOTS-c in models of pulmonary fibrosis, focusing on mitochondrial function and cellular-stress pathways in lung tissue.
• Pharmacological Research, 2022 — explored MOTS-c in the context of gestational diabetes and glucose metabolism.
• Frontiers in Physiology, 2023 — examined MOTS-c's role in bone metabolism and bone-cell function in preclinical models.
• International Journal of Molecular Sciences, 2022 — surveyed MOTS-c in human aging and age-related disease, linking the peptide to metabolic health and cellular-stress responses.

What MOTS-c is studied for

Metabolism and insulin sensitivity. This is the most-developed thread. In mice, MOTS-c activates AMPK and, in the foundational work, reduced diet-induced obesity and insulin resistance -- which is why it is studied as a regulator of how cells handle glucose and fuel.

Muscle and exercise biology. MOTS-c is studied around skeletal muscle and physical stress, including signaling tied to muscle atrophy. Its responsiveness to metabolic demand has made it a peptide of interest in exercise research.

Cellular stress and aging. Because MOTS-c appears to relay mitochondrial stress signals to the nucleus, researchers examine it in aging and age-related decline, where mitochondrial function falls off.

Broader disease models. More exploratory preclinical work has looked at MOTS-c in ovarian cancer, pulmonary fibrosis, gestational diabetes, and bone metabolism. These are early mechanistic studies, not evidence of human benefit.

Storage & handling

As a lyophilized (freeze-dried) powder, MOTS-c reference material is most stable kept cold and dark -- refrigerated for short holds, frozen for longer storage. Once reconstituted with bacteriostatic water it should be refrigerated at about 2-8 C, kept out of light, and protected from repeated freeze-thaw cycles, which degrade peptides. Handle it strictly as a research reagent and see the reconstitution reference below for the concentration math.

Reconstitution reference

Standard laboratory reconstitution volumes for MOTS-c, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.